Semaglutide Weight Loss Clinics in the United States

What Is Semaglutide?

Semaglutide is an FDA-approved GLP-1 receptor agonist that mimics a natural gut hormone to regulate appetite, blood sugar, and digestion. It is the active ingredient in Ozempic (diabetes) and Wegovy (weight loss), as well as the oral tablet Rybelsus.

It works by slowing gastric emptying, increasing satiety signals to the brain, and reducing appetite. Clinical trials showed average weight loss of 15% of body weight over 68 weeks. Beyond weight loss, semaglutide improves insulin sensitivity, reduces cardiovascular risk, and has shown benefits in NASH and kidney disease in ongoing trials.

Semaglutide is administered via weekly subcutaneous injection (or daily oral tablet) and requires physician oversight, including periodic lab monitoring.

Who Considers Semaglutide?

• Adults with obesity (BMI 30+) or overweight (BMI 27+) with a weight-related comorbidity
• People with type 2 diabetes seeking better blood sugar control
• Patients who have not achieved results with diet and exercise alone
• Anyone wanting a medically supervised, evidence-based weight management program

What to Expect at a Consultation

Your first consultation will typically cover your medical history, current weight, any metabolic conditions, medications, and weight loss history. The physician will determine whether semaglutide is appropriate and at what starting dose. Most clinics begin at a low dose and titrate upward over 16-20 weeks to minimize side effects like nausea. Ongoing monitoring includes periodic check-ins and may include lab work to track metabolic markers. Many clinics offer this via telehealth with the medication shipped directly to you.